ArticleCurrent infectious disease reports2011

Clinical Trial Report: TMC278 (Rilpivirine) Versus Efavirenz as Initial Therapy in Treatment-Naïve, HIV-1-Infected Patients.

Rodger D MacarthurPubMed ↗Publisher ↗

No numbers read from the abstract.